RUNX2 as a promising therapeutic target for malignant tumors
Weizhu Zhao,1,2 Haiying Yang,3 Jie Chai,4 Ligang Xing1 1Department of Radiology, Cancer Hospital Affiliated to Shandong First Medical University, Shandong Cancer Hospital and Institute, Jinan, 250117, People’s Republic of China; 2Department of Oncology, Binzhou People’s Hospital,...
Main Authors: | Zhao W, Yang H, Chai J, Xing L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/runx2-as-a-promising-therapeutic-target-for-malignant-tumors-peer-reviewed-article-CMAR |
Similar Items
-
RUNX2 promueve la progresión tumor en osteosarcoma
by: Vega Villa, Óscar Andrés
Published: (2019) -
RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia
by: Wei-De Lin, et al.
Published: (2011-01-01) -
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with <i>RUNX1</i>-<i>RUNX1T1</i> Fusion
by: Jae Won Yun, et al.
Published: (2019-04-01) -
Runx Transcription Factors in T Cells—What Is Beyond Thymic Development?
by: Svetlana Korinfskaya, et al.
Published: (2021-08-01) -
Functions of Exogenous RUNX2 in Giant Cell Tumor of Bone In Vitro
by: Yuan‐han Jin, et al.
Published: (2020-04-01)